Position in AXGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$18,347,493
New position
Shares Held
553,803
first reported quarter
Ownership
1.04%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Medical Devices
Healthcare · as of Mar 31, 2026Holocene Advisors, LP holds $844,866,051 across 15 Medical Devices names. AXGN ranks #9 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
3,428,736 | $215,153,184 | |
| 2 | GKOS |
GLAUKOS Corp
|
1,383,715 | $148,970,756 | |
| 3 | IRTC |
iRhythm Holdings, Inc.
|
1,248,658 | $147,366,617 | |
| 4 | ABT |
Abbott Laboratories
|
790,916 | $81,203,345 | |
| 5 | GMED |
Globus Medical Inc
|
773,834 | $66,673,537 | |
| 6 | EW |
Edwards Lifesciences Corp
|
738,099 | $59,106,967 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
593,705 | $53,682,806 | |
| 8 | PEN |
Penumbra Inc
|
110,614 | $36,322,319 |
All Filings in AXGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,347,493 | 553,803 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||